Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
EKSO BIONICS HOLDINGS, INC. issued 1,311,407 shares of common stock to Applied Parent for $12.01 per share.
- Security
- common stock
- Shares
- 1,311,407 shares
- Purchaser
- Applied Parent
- Consideration
- $12.01 per share
Exact text from the filing
APLD Parent PIPE Investment In connection with, and as a condition to Closing, on May 1, 2026, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Applied Parent (the “APLD Parent PIPE Investment”), pursuant to which the Company agreed to sell and issue to Applied Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”). The Private Placement Shares will be sold in the APLD Parent PIPE Investment at an offering price of $12.01 per share, the closing price of the Common Stock on April 30, 2026, the date immediately preceding the date of execution of the Securities Purchase Agreement, for gross proceeds of approximately $15.75 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
EKSO BIONICS HOLDINGS, INC. entered into Securities Purchase Agreement with Applied Parent valued at gross proceeds of approximately $15.75 million (effective 2026-05-01).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Applied Parent
- Value
- gross proceeds of approximately $15.75 million
- Effective
- 2026-05-01
Exact text from the filing
the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with Applied Parent (the “APLD Parent PIPE Investment”), pursuant to which the Company agreed to sell and issue to Applied Parent 1,311,407 shares of Common Stock (the “Private Placement Shares”).
View on SEC.gov